A large number of broker notes have hit the wires this week, leading to many popular shares being declared buys and sells.
Three shares that are in favour with brokers and have been given a buy rating are listed below. Here's why they are bullish on them:
Aristocrat Leisure Limited (ASX: ALL)
According to a note out of Deutsche Bank, its analysts have retained their buy rating and $39.30 price target on this gaming technology company's shares ahead of its half year results release next week. The broker believes that Aristocrat Leisure is winning market share in North America and suspects that its half year result could surprise to the upside. I agree with Deutsche on Aristocrat Leisure and feel its shares offer a compelling risk/reward at the current level.
Costa Group Holdings Ltd (ASX: CGC)
Analysts at UBS have retained their buy rating but trimmed the price target on the horticulture company's shares slightly to $6.70 ahead of its annual general meeting later this month. According to the note, the broker notes that mushroom prices have been weaker and the Moroccan blueberry season has been softer, but it remains confident that Costa will reiterate its earnings growth guidance of +30% at its meeting on May 30. While it may be prudent to wait for its meeting, if its guidance is reiterated then I think Costa's shares are great value at this price.
CSL Limited (ASX: CSL)
Another note out of UBS reveals that its analysts have retained their buy rating and lifted the price target on this global biotech giant's shares to $223.00. According to the note, the broker believes that immunoglobulins growth remains strong and expects Chinese albumin growth to recover. In addition to this, the broker is positive on the prospects of the company's Seqirus influenza vaccines business and expects it to win market share. I agree with UBS and feel CSL would be a great option for investors.
